These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 34135088)

  • 1. Impact of Interindividual Differences in Plasma Fraction Unbound on the Pharmacokinetics of a Novel Syk Kinase Inhibitor in Beagle Dogs.
    Pike A; Jones B; Markandu R; O'Neill D
    Drug Metab Dispos; 2021 Sep; 49(9):736-742. PubMed ID: 34135088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implications of plasma protein binding for pharmacokinetics and pharmacodynamics of the γ-secretase inhibitor RO4929097.
    Wu J; Lorusso PM; Matherly LH; Li J
    Clin Cancer Res; 2012 Apr; 18(7):2066-79. PubMed ID: 22351688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Canine orosomucoid (alpha-1 acid glycoprotein) variants and their influence on drug plasma protein binding.
    Costa AP; Court MH; Villarino NF; Burke NS; Mealey KL
    J Vet Pharmacol Ther; 2021 Jan; 44(1):116-125. PubMed ID: 32744755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of plasma proteins, albumin and alpha 1-acid glycoprotein, to pharmacokinetics of a multi-targeted receptor tyrosine kinase inhibitor, sunitinib, in analbuminemic rats.
    Toyama Y; Ueyama J; Nomura H; Tsukiyama I; Saito H; Hisada T; Matsuura K; Hasegawa T
    Anticancer Res; 2014 May; 34(5):2283-9. PubMed ID: 24778032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of the ORM1 phenotypes on serum unbound concentration and protein binding of quinidine.
    Li JH; Xu JQ; Cao XM; Ni L; Li Y; Zhuang YY; Gong JB
    Clin Chim Acta; 2002 Mar; 317(1-2):85-92. PubMed ID: 11814462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interethnic scaling of fraction unbound of a drug in plasma and volume of distribution: an analysis of extrapolation from Caucasians to Chinese.
    Yu G; Zhou HH; Zheng QS; Li GF
    Eur J Clin Pharmacol; 2019 Apr; 75(4):543-551. PubMed ID: 30569284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of unbound fraction of pazopanib in vitro and in cancer patients reveals albumin as the main binding site.
    Imbs DC; Paludetto MN; Négrier S; Powell H; Lafont T; White-Koning M; Chatelut E; Thomas F
    Invest New Drugs; 2016 Feb; 34(1):41-8. PubMed ID: 26572909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein binding in antiretroviral therapies.
    Boffito M; Back DJ; Blaschke TF; Rowland M; Bertz RJ; Gerber JG; Miller V
    AIDS Res Hum Retroviruses; 2003 Sep; 19(9):825-35. PubMed ID: 14585213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanistic investigations into the species differences in pinometostat clearance: impact of binding to alpha-1-acid glycoprotein and permeability-limited hepatic uptake.
    Smith SA; Gagnon S; Waters NJ
    Xenobiotica; 2017 Mar; 47(3):185-193. PubMed ID: 27160567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated alpha-1-acid glycoprotein reduces the volume of distribution and systemic clearance of saquinavir.
    Holladay JW; Dewey MJ; Michniak BB; Wiltshire H; Halberg DL; Weigl P; Liang Z; Halifax K; Lindup WE; Back DJ
    Drug Metab Dispos; 2001 Mar; 29(3):299-303. PubMed ID: 11181499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Facing the Facts of Altered Plasma Protein Binding: Do Current Models Correctly Predict Changes in Fraction Unbound in Special Populations?
    Al-Qassabi J; Tan SPF; Phonboon P; Galetin A; Rostami-Hodjegan A; Scotcher D
    J Pharm Sci; 2024 Jun; 113(6):1664-1673. PubMed ID: 38417790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tamsulosin shows a higher unbound drug fraction in human prostate than in plasma: a basis for uroselectivity?
    Korstanje C; Krauwinkel W; van Doesum-Wolters FL
    Br J Clin Pharmacol; 2011 Aug; 72(2):218-25. PubMed ID: 21745239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Orosomucoid (alpha1-acid glycoprotein) plasma concentration and genetic variants: effects on human immunodeficiency virus protease inhibitor clearance and cellular accumulation.
    Colombo S; Buclin T; Décosterd LA; Telenti A; Furrer H; Lee BL; Biollaz J; Eap CB;
    Clin Pharmacol Ther; 2006 Oct; 80(4):307-18. PubMed ID: 17015049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum protein binding of tolterodine and its major metabolites in humans and several animal species.
    Påhlman I; Gozzi P
    Biopharm Drug Dispos; 1999 Mar; 20(2):91-9. PubMed ID: 10206324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of pH on plasma protein binding in equilibrium dialysis.
    Kochansky CJ; McMasters DR; Lu P; Koeplinger KA; Kerr HH; Shou M; Korzekwa KR
    Mol Pharm; 2008; 5(3):438-48. PubMed ID: 18345638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Species differences in plasma protein binding of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) main protease inhibitor nirmatrelvir.
    Greenfield SR; Eng H; Yang Q; Guo C; Byrnes L; Dantonio A; West G; Di L; Kalgutkar AS
    Xenobiotica; 2023 Jan; 53(1):12-24. PubMed ID: 36803165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of gefitinib, an inhibitor of epidermal growth factor receptor-tyrosine kinase, to plasma proteins and blood cells: in vitro and in cancer patients.
    Li J; Brahmer J; Messersmith W; Hidalgo M; Baker SD
    Invest New Drugs; 2006 Jul; 24(4):291-7. PubMed ID: 16502356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unbound Fraction of Clozapine Significantly Decreases with Elevated Plasma Concentrations of the Inflammatory Acute-Phase Protein Alpha-1-Acid Glycoprotein.
    Man WH; Wilting I; Heerdink ER; Hugenholtz GWK; Bognár T; Ten Berg MJ; van Solinge WW; Egberts TACG; van Maarseveen EM
    Clin Pharmacokinet; 2019 Aug; 58(8):1069-1075. PubMed ID: 31111332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic and Pharmacodynamic Considerations for Drugs Binding to Alpha-1-Acid Glycoprotein.
    Smith SA; Waters NJ
    Pharm Res; 2018 Dec; 36(2):30. PubMed ID: 30593605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased binding of verapamil to plasma proteins in patients with liver disease.
    Giacomini KM; Massoud N; Wong FM; Giacomini JC
    J Cardiovasc Pharmacol; 1984; 6(5):924-8. PubMed ID: 6209501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.